<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1208245743
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MINIRIN NASAL SPRAY 0.1MG-ML
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DESMOPRESSIN ACETATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Nasal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Nasal spray, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pressurised container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        148.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="FERRING" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            FERRING
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            FERRING
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        H01BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Minirin is a slightly altered, synthetic modification of the antidiuretic hormone (ADH, vasopressin), which is normally released into<br />the blood stream by the pituitary gland and regulates urine excretion. Minirin is prescribed by doctors to treat illnesses in which the<br />kidneys cannot concentrate urine sufficiently, due to insufficient production of the body&rsquo;s own antidiuretic hormone:<br />- Central diabetes insipidus, polyuria, polydipsia post-hypophysectomy or surgery in the pituitary region.<br />- Testing of renal concentration capacity (diagnosis of diabetes insipidus)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Minirin has no effect in patients whose excess urine excretion is not due to lack of antidiuretic hormone.<br />Do not use Minirin if you have:<br />- Heart defects, heart weakness or heart complaints.<br />- Other diseases requiring treatment with water pills (diuretics) (e.g. high blood pressure).<br />- Abnormal thirst, causing you to drink large amounts of fluid.<br />- Low levels of sodium in your blood (hyponatraemia).<br />- A syndrome of excessive secretion of antidiuretic hormone (ADH).<br />- Impaired kidney function.<br />- Hypersensitivity to any of the ingredients.<br />Minirin is not suitable for the treatment of bleeding or bleeding disorders.<br /><strong>Take special care when taking/using Minirin Nasal Spray</strong><br />If you or your child is treated with Minirin, please ensure that you or your child avoid excessive fluid intake (drinking very large amounts).<br />This also includes swallowing water during sports activities, such as swimming. Parents should supervise their children in this respect.<br />If you do not simultaneously limit your fluid intake, treatment with Minirin can lead to excess fluid levels in the body and to sodium<br />depletion in the blood, even at the correct dosage. Signs of these disturbances are weight gain, headache, nausea, vomiting and<br />oedema (collection of water in the tissues). If you notice any such symptoms in yourself or your child, contact your doctor immediately.<br />If you suffer from fluid or salt imbalances, e.g. due to vomiting, diarrhoea, infectious diseases and fever, you should contact your<br />doctor, as your Minirin dose may need to be adjusted. Particular caution is urged if you suffer from raised pressure in the brain<br />(intracranial pressure). Particular caution is urged in very young and elderly patients, as such patients may react more sensitively to<br />use of Minirin.<br />Simultaneous intake of Minirin and any of the following medicines can enhance the effect of Minirin, thereby increasing the risk of<br />excess fluid in the body:<br />- Anti-rheumatic medicines with the active substance indometacin;<br />- Medicines to reduce blood fats with the active substance clofibrate;<br />- Medicines to induce labour in childbirth with the active substance oxytocin;<br />- Medicines to treat epilepsy with the active substance carbamazepine;<br />- Medicines to treat depression with so-called tricyclic antidepressants or serotonin re-uptake inhibitors;<br />- Medicines to treat psychiatric disorders with the active substance chlorpromazine;<br />- Medicines with effects on the body&rsquo;s water and salt balance, such as those containing the active substance chlorpropamide;<br />- Medicines to treat diarrhoea with the active substance loperamide.<br />Simultaneous intake of lithium (to treat mania) or medicines that reduce blood sugar with the active substance glibenclamide can<br />weaken the effect of Minirin.<br />If you are taking medicines to treat high blood pressure, it is important that your doctor regularly monitors your blood pressure, the<br />sodium content of your blood and your urine excretion.<br />Scarring or swelling of the nasal mucosa (due to a runny nose) can lead to irregular absorption of the active substance contained in<br />Minirin Nasal Spray.<br />If hypersensitivity reactions occur, as can happen in rare cases (see below: &rdquo;What side effects can Minirin Nasal Spray have?&rdquo;), you<br />must discontinue treatment immediately and tell a doctor.<br />Tell your doctor or pharmacist if you are suffering from any other diseases, if you have any allergies or if you are taking any other<br />medicines (including those obtained without a prescription) or are using them externally!<br /><strong>Taking/using Minirin Nasal Spray during pregnancy or while breast-feeding</strong><br />Minirin&reg; falls under B of pregnancy categories.<br /><strong>Pregnancy</strong><br />In pregnant women suffering from deficiency of the body&rsquo;s own antidiuretic hormone, Minirin treatment can be continued during<br />pregnancy. It must be borne in mind, however, that the requirement for Minirin can increase during pregnancy. Pregnant women<br />who require Minirin daily should therefore tell their doctor at the beginning of the pregnancy about their Minirin use. If you use Minirin<br />during pregnancy, your doctor should check your blood pressure regularly.<br /><strong>Breast-feeding:</strong><br />Only small quantities of Minirin pass into breast milk. Minirin has no effect on breast-fed infants.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Your doctor will decide on the dosage and duration of treatment on an individual basis. If you have a deficiency of the body&rsquo;s own<br />antidiuretic hormone, your doctor will usually prescribe the following amounts for you to use/take:<br />Central diabetes insipidus, polyuria, polydipsia post-hypophysectomy or surgery in the pituitary region<br />Adults: The dose is 10&ndash;40 divided doses, corresponding to: 1&ndash;4 actuations daily (maximum daily dose: 2 x 2 actuations).<br />Children: The dose is 5&ndash;20 divided doses, corresponding to: 1&ndash;2 actuations daily (maximum daily dose: 2 x 1 actuation).<br />Renal concentrating capacity test:<br />Adults: 40 nasal spray actuations).<br />Children aged 10-16 years: 20 nasal spray actuations).<br />Infants and toddlers: 10 nasal spray actuation).<br />Instructions on the correct use of Minirin Nasal Spray:<br />1. Remove the protective cap.<br />2. Hold the spray bottle as shown in Figure 2. Before the first use or if the spray bottle has not been used for 1 week or longer:<br />Depress the pump valve (about 4 times) until the pump delivers an even spray. Make sure that the end of the tube in the spray bottle<br />always remains immersed in fluid. (A)<br />3. Tip your head back slightly and insert the spray tube into one nostril (do not push the spray tube too far into your nose). Hold your<br />breath and depress the pump valve once.<br />4. If the prescribed dose is 2 actuations, repeat the procedure in your other nostril according to Point 3. If the prescribed dose is<br />more than 2 actuations, you must wait for approximately 5 minutes before spraying the first nostril again.<br />5. Replace the protective cap. Always store the spray bottle in an upright position.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The following side effects can occur following intake or use of Minirin:<br />Common side effects are tiredness, headache, abdominal pain and cramps, nausea, diarrhoea, a temporary fall in blood pressure,<br />increased pulse rate and facial flush. Following use of the nasal drops or nasal spray, a blocked nose, nose bleeds or a runny<br />nose are common occurrences. Very rarely, abnormal retention of water in the tissues and an excessively low sodium level in the<br />blood can occur, sometimes resulting in cramps, cerebral oedema and deep unconsciousness (coma). Furthermore, in very rare<br />cases, allergic reactions (hypersensitivity reactions), such as itching, skin rash, fever, bronchial cramps or general allergic reactions<br />resembling shock occur. Emotional disturbances in children undergoing treatment for bed-wetting have also been observed.<br />In addition, blood clotting problems (thrombosis in the blood vessels of the brain and the coronary arteries) can occur.<br />If you notice any side effects not mentioned in this leaflet, please tell your doctor or pharmacist.<br />If overdose occurs, there is a risk of excess water retention in the body. Signs of this condition include raised blood pressure, raised<br />pulse rate, facial flush, headache, cramps, nausea and abdominal cramps. In severe cases, general convulsions, cerebral oedema<br />and deep unconsciousness (coma) are likely.<br />Contact your doctor immediately. All cases of suspected cerebral oedema (convulsions and unconsciousness) require immediate<br />admission to an intensive care unit.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>To be kept at room temperature (below 30&deg;C). Do not freeze. After opening the bottle, Minirin&reg;<br />Nasal Spray can be stored<br />for 8 weeks at room temperature. Store Minirin&reg; in the original packaging protected from light and moisture.<br />Store all medicines out of the reach and sight of children.<br />The medicine may only be used until the date marked with &ldquo;EXP&rdquo; on the container.<br />If you need any further information, please ask your doctor or pharmacist.<br />These persons have access to the more detailed Information for Healthcare Professionals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Active substance: desmopressin acetate.<br />Other ingredients: sodium chloride, citric acid monohydrate, disodium phosphate dihydrate,<br />preservatives: benzalkonium chloride 0.1 mg, purified water q.s. 1 mls</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                In pharmacies and only on medical prescription. Bottle containing 2.5 ml or 5 ml.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufacturer: FERRING GmbH, Wittland 11, D-24109 Kiel, Germany<br />Marketing authorization holder:FERRING International Center SA,<br />Chemin de la Vergognausaz 50,<br />1162 St. Prex, Switzerland</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                August 2012.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>مينيرين هو تعديل اصطناعي بسيط للهرمون المضاد لإدرار البول( ADH,سوبريسين)&nbsp;والذي يتم تحريره عادة في مجرى الدم من الغدة النخامية وينظم تفريغ البول. ويوصف&nbsp;مينيرين من قبل الأطباء لعلاج الأمراض التي بسببها لا تستطيع الكلى تركيز البول بما فيه الكفاية، بسبب نقص إنتاج الهرمون المضاد لإدرار البول في الجسم.<br />- مرض السكري التفه المركزي )البوال التفه( والبوال والعطاش بعد استئصال الغدة النخامية أو عملية جراحية في المنطقة النخامية.<br />- فحص قدرة تركيز الكلى (تشخيص مرض السكري التفه المركزي (البوال التفه)).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>مينيرين ليس له أي تأثير في المرضى الذين لديهم تفريغ بول زائد غير ناتج عن نقص الهرمون المضاد لإدرار البول.<br />لا تستخدم مينيرين إذا كان لديك:<br />- عيوب القلب، وضعف القلب أو شكاوى القلب.<br />- الأمراض الأخرى التي تتطلب العلاج بحبوب الماء(مدرات البول)(مثل ارتفاع ضغط الدم).<br />- عطش غير طبيعي، الذي يتسبب لك في شرب كميات كبيرة من السوائل.<br />- انخفاض مستويات الصوديوم في الدم(نقص صوديوم الدم).<br />&nbsp;- متلازمة فرط إفراز الهرمون المضاد لإدرار البول(ADH)<br />- اختلال وظائف الكلى.<br />- فرط الحساسية لأي من المكونات.<br />إن مينيرين غير مناسب لعلاج النزيف أو الاضطرابات النزفية.</p><p><strong>ينبغي توخي الحذر عند تناول مينيرين بخاخ للانف</strong><br />إذا تم علاجك أو علاج طفلك بمينيرين، الرجاء التأكد من تفادي طفلك من الإفراط في كمية سوائل (شرب كميات كبيرة جدا) لك ولطفلك. وهذا يشمل أيضا ابتلاع الماء أثناء ممارسة<br />الأنشطة الرياضية، مثل السباحة. ويجب على الآباء الإشراف على أطفالهم في هذا المجال.<br />إذا كنت لا تحد في نفس الوقت من تناول السوائل، فالمعالجة بمينيرين قد تؤدي إلى زيادة مستويات السوائل في الجسم وإلى نقص الصوديوم في الدم حتى على الجرعة الصحيحة. علامات هذه<br />الاضطرابات هي زيادة الوزن والصداع والغثيان والتقيؤ والوذمة (تجمع الماء في الأنسجة).<br />إذا لاحظت أي من هذه الأعراض في نفسك أو في طفلك، اتصل بطبيبك فورا.<br />إذا كنت تعاني من اختلال في توازن السوائل أو الملح، مثلا بسبب التقيؤ والإسهال والأمراض المعدية والحمى، يجب عليك الاتصال بطبيبك، كما قد تحتاج إلى تعديل جرعة مينيرين. وينبغي توخي<br />حذر خاص إذا كنت تعاني من ارتفاع الضغط في الدماغ(الضغط داخل الجمجمة).<br />وينبغي توخي حذر خاص في المرضى الصغار جدا والمسنين، بما أن مثل هؤلاء المرضى يكون لديهم رد فعل أكثر حساسية لإستخدام مينيرين.<br />التناول المتزامن لمينيرين وأي من الأدوية التالية قد يعزز من تأثير مينيرين، مما يزيد من خطر زيادة السوائل في الجسم:</p><p>- الأدوية المضادة للروماتيزم مع المادة الفعالة إندوميتاسين.<br />- أدوية لتقليل الدهون في الدم مع المادة الفعالة كلوفيبرات.<br />- أدوية لحث المخاض في الولادة مع المادة الفعالة الأوكسيتوسين.<br />- أدوية لعلاج الصرع مع المادة الفعالة كاربامازيبين.<br />- أدوية لعلاج الاكتئاب مع ما يسمى مضادات الاكتئاب ثلاثية الحلقات أو مثبطات إعادة امتصاص السيروتونين.<br />- أدوية لعلاج الاضطرابات النفسية مع المادة الفعالة الكلوربرومازين.<br />- الأدوية التي تؤثر على توازن الماء والاملاح في الجسم مثل تلك التي تحتوي على المادة الفعالة كلوربروباميد.<br />- أدوية لعلاج الإسهال مع المادة الفعالة لوبيراميد.<br />قد يضعف التناول المتزامن من الليثيوم(لعلاج الهوس) أو الأدوية التي تقلل من نسبة السكر في الدم مع المادة الفعالة غليبينكلاميد من تأثير مينيرين.<br />إذا كنت تأخذ أدوية لعلاج ارتفاع ضغط الدم، فمن المهم أن طبيبك يراقب بانتظام ضغط الدم ومحتوى الصوديوم في الدم وتفريغ البول.<br />قد يؤدي تندب أو تورم الغشاء المخاطي للأنف(بسبب سيلان الأنف) إلى امتصاص غير منتظم من المادة الفعالة الواردة في مينيرين بخاخ للأنف.<br />إذا حدثت تفاعلات فرط الحساسية، كما يمكن أن يحدث في حالات نادرة(انظر أدناه: &quot;ما هي الآثار الجانبية التي يمكن أن تحدث مع مينيرين بخاخ للأنف؟&quot;)، يجب عليك التوقف عن<br />العلاج فورا وأخبر الطبيب.<br />أخبر طبيبك أو الصيدلي إذا كنت تعاني من أي أمراض أخرى، إذا كان لديك أي نوع من الحساسية أو إذا كنت تأخذ أي أدوية أخرى(بما في ذلك تلك التي تم الحصول عليها دون وصفة طبية)<br />أو يتم استخدامها خارجيا!</p><p><strong>تناول / استخدام مينيرين بخاخ للانف أثناء الحمل أو أثناء الرضاعة الطبيعية</strong><br />من فئات أدوية الحمل. B يقع مينيرين تحت فئة<br />فترة الحمل<br />في النساء الحوامل التي تعاني من نقص الهرمون المضاد لإدرار البول في الجسم، يمكن أن يستمر العلاج بمينيرين خلال فترة الحمل. مع ذلك، يجب أن يوضع في الاعتبار، أن طلب<br />مينيرين يمكن أن يزيد<br />خلال فترة الحمل. لذلك يجب على النساء الحوامل التي تحتاج إلى مينيرين يوميا إخبار الطبيب في بداية الحمل عن استخدامهن لمينيرين. إذا كنت تستخدمين مينيرين خلال فترة الحمل،<br />يجب أن يفحص طبيبك ضغط دمك بانتظام</p><p>الرضاعة الطبيعية<br />فقط كميات صغيرة من مينيرين تنتقل إلى حليب الثدي. مينيرين ليس له تأثير على الأطفال الذين يرضعون من الثدي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سيقرر طبيبك بشأن الجرعة ومدة العلاج على أساس فردي. إذا كان لديك نقص هرمون المضاد لإدرار البول في الجسم ، سيقوم الطبيب عادة بوصف الكميات التالية لاستخدامها / تناولها:<br />مرض السكري التفه المركزي (البوال التفه)والبوال والعطاش بعد استئصال الغدة النخامية أو عملية جراحية في المنطقة النخامية<br />البالغين: الجرعة هي 40-10&nbsp;ميكروغرام يوميا، في 2-1&nbsp;جرعة مقسمة، والتي تعادل: 4-1 بخات يوميا (الجرعة اليومية القصوى: 2x2 بخة )</p><p>الأطفال: الجرعة هي 20-5 ميكروغرام يوميا، في 2-1&nbsp;جرعة مقسمة، والتي تعادل: 2-1 بخة يوميا (الجرعة اليومية القصوى: 1x2 بخة )<br />فحص قدرة تركيز الكلى (تشخيص مرض السكري التفه المركزي(البوال التفه))<br />البالغين: 40 ميكروغرام ( 4 بخات في الأنف).<br />الأطفال بين عمر 16-10&nbsp;سنة: 20 ميكروغرام (2 بخة في الأنف).<br />الرضع والأطفال الصغار: 10 ميكروغرام ( 1 بخة في الأنف).</p><p><strong>إرشادات حول الاستخدام الصحيح لمينيرين بخاخ الأنف:</strong></p><p>1. إزالة الغطاء الواقي.<br />2 . امسك زجاجة البخاخ كما هو مبين في الشكل 2. قبل الاستخدام لأول مرة أو في حالة عدم استخدام زجاجة البخاخ لمدة أسبوع أو أكثر: اضغط على صمام المضخة )حوالي 4 مرات( حتى<br />)A( . تعطي المضخة بخة مكتملة. تأكد من أن نهاية الأنبوب في زجاجة البخاخ دائما مغمورة في السائل<br />3 . أمَِلْ رأسك للخلف قليلا وأدخل أنبوب البخاخ في إحدى فتحتي الأنف )لا تضغط على الأنبوب البخاخ كثير إلى الداخل في أنفك(. احبس أنفاسك واضغط صمام المضخة مرة واحدة.<br />4 . إذا كانت الجرعة الموصوفة هي بختين، كرر العملية في فتحة أنفك الأخرى وفقا للنقطة 3. وإذا كانت الجرعة الموصوفة أكثر من بختين، يجب عليك الانتظار لمدة 5 دقائق تقريبا<br />قبل رش فتحة أنفك الأولى مرة أخرى.<br />5 . أرجع الغطاء الواقي. وخزن دائما زجاجة البخاخ في وضع رأسي.</p><p>لا تقم بتغيير الجرعة الموصوفة بناء على مبادرتك الشخصية. إذا كنت تشعر بأن تأثير الدواء ضعيف جداً أو قوي جداً، يرجى التحدث إلى طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>قد تحدث الآثار الجانبية التالية بعد تناول أو استخدام مينيرين:<br />الآثار الجانبية الشائعة هي التعب والصداع وآلام في البطن وتشنجات وغثيان وإسهال وإنخفاض مؤقت في ضغط الدم وزيادة معدل النبض وإحمرار الوجه. والأحداث الشائعة بعد استخدام بخاخ<br />الأنف، هي انسداد الأنف ونزيف الأنف أو سيلان الأنف. نادرا جدا، قد يحدث احتباس غير طبيعي للماء في الأنسجة وانخفاض مستوى الصوديوم في الدم بشكل مفرط، مما يؤدي في<br />بعض الأحيان<br />إلى تشنجات ووذمة دماغية وغيبوبة عميقة(حالة غيبوبة). بالاضافة إلى ذلك، في حالات نادرة جدا، تحدث ردود فعل تحسسية (تفاعلات فرط الحساسية)، مثل الحكة، الطفح الجلدي، والحمى،<br />وتشنجات الشعب الهوائية أو تفاعلات تحسسية عامة تشبه الصدمة. كما لوحظت اضطرابات عاطفية في الأطفال الذين يخضعون لعلاج التبول في الفراش. وبالإضافة إلى ذلك، يمكن أن<br />تحدث مشاكل تخثر الدم(تجلط الدم في الأوعية الدموية في الدماغ والشرايين التاجية).<br />إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي. إذا تم حدوث الجرعة الزائدة، هناك خطر من احتباس الماء الزائد في الجسم. وتشمل<br />علامات هذه الحالة ارتفاع ضغط الدم، وارتفاع معدل النبض، واحمرار الوجه، والصداع، والتشنجات، والغثيان وتقلصات في البطن. من المرجح في الحالات الشديدة، تشنجات عامة،<br />ووذمة دماغية وغيبوبة عميقة<br />(حالة غيبوبة). اتصل بطبيبك على الفور. جميع حالات الوذمة الدماغية المشتبه بها (التشنجات وفقدان الوعي)تتطلب الدخول الفوري إلى وحدة العناية المركزة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>خزن مينيرين بخاخ للأنف تحت درجة حرارة 25 درجة مئوية. بعيداً عن الضوء والرطوبة. بعد فتح الزجاجة، يمكن تخزين مينيرين بخاخ للأنف لمدة 8 أسابيع في درجة حرارة الغرفة.</p><p>خزن جميع الأدوية بعيدا عن بصر ومتناول الأطفال. يمكن استخدام الدواء فقط حتى التاريخ الذي يحمل علامة &quot;انتهاء&quot; على العبوة الخارجية.<br />إذا كنت تريد مزيدا من المعلومات، من فضلك إسأل الدكتور أو الصيدلي. يمكن لهؤلاء الأشخاص الوصول إلى معلومات أكثر تفصيلا لمقدمي الرعاية الصحية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة: أسيتات الديسموبريسين،<br />المكونات الأخرى: كلوريد الصوديوم، مونوهيدرات حامض الستريك، الصوديوم ثنائي هيدرات<br />الصوديوم ثنائي الفوسفات، والمواد الحافظة: كلوريد البنزالكونيوم 0.1 ملغ، والمياه النقية حتى 1 مل.<br />البخة الواحدة تحتوي على 10 ميكروغرام أسيتات الديسموبريسين.<br />1 زجاجة من 2،5 مل تحتوي على 250 ميكروغرام أسيتات الديسموبريسين، ما يعادل 25 بخة.<br />1 زجاجة من 5 مل تحتوي على 500 ميكروغرام أسيتات الديسموبريسين، ما يعادل 50 بخة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>1 زجاجة من 2،5 مل تحتوي على 250 ميكروغرام أسيتات الديسموبريسين، ما يعادل 25 بخة.<br />1 زجاجة من 5 مل تحتوي على 500 ميكروغرام أسيتات الديسموبريسين، ما يعادل 50 بخة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>المصنع: فيرينغ جي ام بي اتش، ويتلاند D-24109-11 كييل، المانيا.</p><p>مالك حق التسويق: فيرنغ انترناشونال سنتر اس اي، 50 كيمن دي لا فيروغوغنوزاز، 1162 سانت بريكس سويسرا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أغسطس 2012
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MINIRIN®
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance: desmopressin acetate
Excipients:
sodium chloride, citric acid monohydrate, disodium phosphate dihydrate, preservatives: benzalkonium chloride
0.1 mg, purified water q.s. 1 ml
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10 μg desmopressin acetate, equivalent to 8.9 μg desmopressin per 0.1 ml actuation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Central diabetes insipidus, polyuria, polydipsia post-hypophysectomy or surgery in the pituitary region.</p><p>Nocturnal enuresis in patients aged 5 years and older with normal renal concentration capacity, after failure of<br />usual measures, only in patients with normal blood pressure and after exclusion of organic cause, for shortterm<br />treatment. The nasal forms of Minirin (nasal drops and nasal spray) must not be used for the treatment of<br />nocturnal enuresis.<br />Testing of renal concentration capacity (diagnosis of diabetes insipidus).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Central diabetes insipidus, polyuria, polydipsia post-hypophysectomy or surgery in the pituitary region<br />At the start of treatment, the optimal dosage must be individually established by the physician by determining<br />urine volume and urine osmolality. Treatment should be aligned to two parameters: an adequate duration of<br />sleep and an equilibrated water balance.<br />Intranasal use<br />Adults: daily dose 10&ndash;40 &mu;g, equivalent to 1&ndash;4 nasal spray actuations, divided into 1 &ndash; 2 single doses.<br />Children: daily dose 5&ndash;20 &mu;g, equivalent to 1&ndash;2 nasal spray actuations, divided into 1&ndash;2 single doses. Minirin<br />nasal spray is unsuitable for the treatment of children requiring a dose of 5 &mu;g, as dosages below 10 &mu;g cannot<br />be administered with the nasal spray.<br />Testing of renal concentration capacity<br />Testing of renal concentration capacity with Minirin in infants below 1 year of age should be performed only<br />under hospital conditions.<br />The short test should preferably be performed in the morning. The amount of ingested fluids should be<br />restricted during the first 12 hours after application. Children below 5 years of age and patients with heart<br />disease or high blood pressure should reduce their fluid intake by one-half.<br />Urine osmolality should be determined before the start of the test. Following administration of desmopressin,<br />2 urine samples are taken (preferably after about 2 and 4 hours). Within the first hour, urine should be taken<br />and discarded. Osmolality is determined in both urine samples. To determine renal concentration capacity, the<br />higher value is compared with the baseline value before the start of the test or with the age-specific reference<br />value (adults: 800-1000 mOsm/kg). Low values and no or only minimal increase in urine osmolality indicate<br />impaired renal concentration capacity. Polyuria related to central diabetes insipidus is present when there is a<br />significant increase in urine osmolality and a significant decrease in urine volume.<br />Intranasal use<br />Adults: 40 &mu;g (4 nasal spray actuations).<br />Children aged 10-16 years: 20 &mu;g (2 nasal spray actuations).<br />Infants and toddlers: 10 &mu;g (1 nasal spray actuation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Desmopressin must not be used in the following cases:
- primary or psychogenic polydipsia;
- heart failure and other diseases requiring treatment with diuretics;
- in patients with hyponatraemia;
- mild or severe renal insufficiency (creatinine clearance below 50 ml/min);
- syndrome of inappropriate ADH secretion (SIADH);
- severe classic von Willebrand-Jürgen’s syndrome (type IIb), patients with 5% factor VIII activity, factor
VIII antibodies;
hypersensitivity to the active substance or to any of the excipients.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>When administering Minirin tablets or sublingual tablets for nocturnal enuresis, fluid intake should be<br />restricted as a precaution 1 hour before and up to 8 hours after administration of Minirin and reduced to<br />quenching the thirst only. Treatment without concomitant reduction in fluid intake can lead to water retention<br />and/or hyponatraemia with symptoms of headache, nausea, vomiting, weight gain and, in severe cases, cerebral<br />oedema, seizures and coma. The safety of long-term use in nocturnal enuresis has not been established.<br />There have been repeated reports of cerebral oedema and seizures occurring in otherwise healthy children and<br />young adults treated with desmopressin for nocturnal enuresis. This risk seems to be particularly high in the<br />first week of treatment.<br />Elderly patients (&gt;65 years of age) and patients with low sodium levels may be at increased risk of<br />hyponatraemia.<br />The duration of action increases at higher dosages and hence also the risk of hyponatraemia. The dosage should<br />be titrated upwards accordingly.<br />Desmopressin should be used with particular caution in patients with cystic fibrosis, coronary heart disease,<br />hypertension, thrombotic tendency, chronic renal disease, pre-eclampsia, increased intracranial pressure or<br />with fluid and electrolyte imbalances.<br />In patients with hypertension and chronic renal disease, the symptoms mentioned under &ldquo;Undesirable effects&rdquo;<br />may be accentuated. In very young and elderly patients, or if risk factors exist that may lead to increased<br />intracranial pressure, care must be taken whilst using Minirin to ensure that no water retention occurs.<br />Without concomitant restriction of fluid intake, treatment with desmopressin can lead to water retention and<br />hyponatraemia.<br />Patients and, in the case of children, their parents should be informed that excessive fluid intake must be<br />avoided and that, in the event of vomiting, diarrhoea, systemic infections and fever, desmopressin use should<br />be suspended until the fluid balance has returned to normal.<br />To reduce the risk of hyponatraemia or water intoxication, a reduction in fluid intake is particularly important:<br />- when using medicinal products known to induce SIADH (tricyclic antidepressants, selective serotonin<br />reuptake inhibitors, chlorpromazine, chlorpropamide and carbamazepine);<br />- during concomitant treatment with NSAIDs.<br />It is important to monitor body weight during treatment.<br />In patients over 65 years of age, serum sodium should be determined before the start of therapy and 3 days<br />after the start of therapy or dose escalations. Treatment must be discontinued at the onset of headache and/or<br />nausea.<br />Organic causes for polyuria or increased urination rate or nocturia, such as benign prostatic hyperplasia (BPH),<br />urinary tract infections, bladder stones or tumours, bladder sphincter disorders, polydipsia or poorly treated<br />diabetes mellitus, should be excluded or treated accordingly. Any adrenal or thyroid insufficiency must be<br />treated before the start of desmopressin therapy.<br />With intranasal use, changes in - or diseases of - the nasal mucosa may lead to altered absorption. In these<br />cases, desmopressin should not be used. The preservative contained in Minirin nasal spray (benzalkonium<br />chloride) may lead to bronchospasms and, especially in prolonged use, may cause swelling of the nasal<br />mucosa. If such a reaction is suspected (persistent blocked nose), a medicinal product for nasal use without<br />preservatives should - as far as possible - be used. If such medicines are not available, a different formulation<br />should be considered.<br />Patients with rare hereditary problems of galactose intolerance, lactase deficiency or glucose-galactose<br />malabsorption should not take Minirin tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If oxytocin is co-administered, an increase in the antidiuretic effect is possible and a reduction in uterine<br />perfusion is likely. Glibenclamide and lithium can reduce the antidiuretic effect of Minirin.<br />Clofibrate, indometacin and other NSAIDs, chlorpromazine, carbamazepine, antidepressants, selective<br />serotonin reuptake inhibitors and all medicinal products that affect the fluid/electrolyte balance can potentiate<br />the antidiuretic effect of Minirin and thus increase the risk of water retention/hyponatraemia. Blood pressure,<br />plasma sodium levels and urine output should be monitored during concomitant use of the above medications.<br />Concomitant treatment with loperamide can result in an up to 3-fold increase in desmopressin plasma<br />concentrations which, in turn, can lead to an increased risk of water retention/hyponatraemia.<br />Desmopressin is unlikely to interact with substances that affect hepatic metabolism, as desmopressin shows no<br />significant hepatic metabolism in in vitro studies on human microsomes. To date, no in vivo studies on<br />potential interactions have been performed.<br />A standardised diet with 27% fat significantly reduces the absorption (amount and duration) of orally<br />administered desmopressin. With regard to pharmacodynamic properties (urine production or osmolality), no<br />significant effect has been observed. Thus, desmopressin can, if desired, be taken with a meal. However, at a<br />low oral desmopressin dosage, food intake can reduce the intensity and duration of the antidiuretic effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The available data in a limited number (n=53) of pregnant women with diabetes insipidus show that<br />desmopressin has no negative effects on pregnancy or the state of health of the foetus or neonate. To date, no<br />other relevant epidemiological data are available. Animal studies do not indicate direct or indirect harmful<br />effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.<br />Caution should be exercised when prescribing to pregnant women.<br />When treating diabetes insipidus in pregnancy, the dose must be adjusted to individual requirements, as these<br />may change during the pregnancy. Blood pressure monitoring is recommended.<br />Tests on the breast milk of women, who were given a high dosage of 300 &mu;g desmopressin (intranasally),<br />showed the amounts of desmopressin that might be transferred to the infant are too low to influence diuresis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No corresponding studies have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The undesirable effects are classified according to organ classes and degrees of frequency, taking into account<br />the following definition: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100);<br />rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).<br />Immune system disorders:<br />Very rare: allergic reactions and hypersensitivity reactions (e.g. pruritus, exanthema, fever, bronchospasm,<br />anaphylaxis)<br />Metabolism disorders:<br />Very rare: hyponatraemia, water intoxication<br />Psychiatric disorders:<br />Very rare: emotional disturbances (in children)<br />Nervous system disorders:<br />Common: headache<br />Rare: cerebral oedema, hyponatraemic seizures<br />Respiratory, thoracic and mediastinal disorders<br />Common: (nasal drops, nasal spray) nasal congestion, epistaxis, rhinitis<br />Gastrointestinal disorders:<br />Common: abdominal pain, cramps, nausea, diarrhoea, vomiting<br />Vascular disorders:<br />Common: transient hypotension, increased pulse rate, flushing<br />Not known: thrombotic complications (cerebral and coronary arteries)<br />General disorders and administration site conditions:<br />Common: fatigue<br />If fluid intake is excessive or if excessively high dosages are used, weight gain, hyponatraemia, seizures,<br />cerebral oedema and coma may occur as a result of water retention. This particularly applies to children up to<br />1 year of age or elderly patients, depending on their general state of health. To avoid water intoxication, an<br />equilibrated water balance should be ensured.<br />Blood pressure may rise due to increased water reabsorption and hypertension may develop in some cases.<br />Angina pectoris may occur in patients with coronary heart disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of acute overdose with Minirin, the above-mentioned undesirable effects may be accentuated.<br />Overdose may occur particularly when the dose is carelessly titrated in infants.<br />There is an increased risk of fluid retention and hyponatraemia in the event of overdose. Although treatment of<br />hyponatraemia should be individualised, the following general recommendations have been tried and tested:<br />In the case of asymptomatic hyponatraemia, treatment with desmopressin is discontinued and fluid intake<br />restricted. If hyponatraemia is symptomatic, infusions of isotonic or hypertonic saline solution can additionally<br />be given. For cerebral oedema, immediate admission for intensive care therapy is necessary. Childhood<br />seizures also require intensive care measures.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>N/A</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />The systemic availability of intravenously administered desmopressin is virtually complete; that of<br />subcutaneously administered desmopressin is approximately 90% compared with intravenous administration.<br />tmax is less than 20 minutes with IV injection and about 1 hour with subcutaneous injection.<br />Minirin, intranasally and orally administered, is rapidly but incompletely absorbed, whereby bioavailability<br />after intranasal administration is about 3&ndash;5% compared with IV administration. Following intranasal<br />administration of desmopressin, the peak plasma concentration is reached after about 50 min.<br />The plasma half-life is between 2 and 3 hours.<br />The absolute bioavailability of desmopressin after oral administration is between 0.08 and 0.16%. The mean<br />peak plasma concentration is reached after about 2 hours.<br />The mean systemic bioavailability of sublingually administered desmopressin such as Minirin Melt at doses of<br />200, 400 and 800 &mu;g is 0.25% with a 95% confidence interval of 0.21&ndash;0.31%. Cmax was 14, 30 and 65 pg/ml<br />after administration of 200, 400 and 800 &mu;g, respectively. tmax was observed 0.5&ndash;2.0 hours post-dose. The<br />geometric mean half-life is 2.8 (CV = 24%) hours.<br />Desmopressin exhibits high variability in bioavailability both inter- and intraindividually.<br />Distribution<br />The volume of distribution is 0.2&ndash;0.3 l/kg. Desmopressin does not cross the blood/brain barrier. Desmopressin<br />passes into breast milk in very small amounts.<br />Metabolism<br />With human liver microsomes, it was shown in vitro that only a small fraction of desmopressin is metabolised<br />in the liver. Thus, the hepatic metabolism of desmopressin in vivo is of little importance.<br />Elimination<br />The elimination of desmopressin follows first-order kinetics, but runs somewhat more slowly than the<br />elimination of native vasopressin. The plasma half-life of desmopressin is between 2.5 and 4.5 hours after<br />parenteral and intranasal administration and between 2.0 and 3.2 hours after oral administration.<br />Approximately 65% of desmopressin absorbed after oral administration (after IV injection: 45%) is excreted<br />within 24 hours via the urine.<br />Kinetics of special patient groups<br />There are no gender-specific differences in the pharmacokinetic behaviour of desmopressin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>From chronic toxicity studies, there are no data to suggest that hitherto unknown side effects might occur in<br />humans.<br />There was no indication of mutagenic potential in an Ames test. No long-term studies have been performed to<br />investigate carcinogenic potential.<br />Embryotoxicity studies, after subcutaneous administration of no more than 10 &mu;g/kg desmopressin on Days 6-<br />18 post conception in rabbits, revealed a higher post-implantation loss of 10.6% in the high-dose group<br />compared with controls (1.2%) and a lower number of living foetuses. No teratogenic effects were observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>sodium chloride, citric acid monohydrate, disodium phosphate dihydrate, preservatives: benzalkonium chloride<br />0.1 mg, purified water q.s. 1 ml</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>N/A</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This medicinal product must not be used after the date, which is stated on the pack after “Exp”.
After opening, the nasal spray has a shelf life of 2 months at 25°C max.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>To be kept at room temperature (below 30&deg;C). Do not freeze. After opening the bottle, Minirin Nasal Spray can<br />be stored for 8 weeks at room temperature. Store Minirin in the original packaging protected from light and<br />moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>N/A</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>N/A</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing authorisation holder: Ferring International Center SA,Chemin de la Vergognausaz 50,1162 St-Prex,Switzerland
Manufacturer:Ferring GmbH,Wittland 11-24109 Kiel,Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2012
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>